Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Vitamin d and multiple sclerosis.
Impaired Object Handling during Bimanual Task Performance in Multiple Sclerosis.
Inflammatory bowel disease: An archetype disorder of outer environment sensor systems.
Induction of multiple sclerosis and response to tyrosine kinase inhibitors.
Role of serine proteases in inflammation: Bowman-Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases.
Cost of disorders of the brain in Spain.
Tetracyclines inhibit human synovial collagenase in vivo and in vitro.
FDA Drug Safety Communication: FDA investigating rare brain infection in patient taking Gilenya (fingolimod)
Prevalence of multiple sclerosis in Al Quseir city, Red Sea Governorate, Egypt.
Treatment patterns in multiple sclerosis: administrative claims analysis over 10 years.
Perception of affective prosody in patients at an early stage of relapsing-remitting multiple sclerosis.
Remission with fingolimod in a case of demyelinating polyneuropathy.
A selective thyroid hormone β receptor agonist enhances human and rodent oligodendrocyte differentiation.
Encephalitis followed by optic neuritis: a case report and review of literature.
Effects of yoga interventions on fatigue: a meta-analysis.
Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis
Multiple sclerosis: the role of cytokines in pathogenesis and in therapies.
Blood-Brain Barrier Disruption is More Severe in Neuromyelitis Optica than in Multiple Sclerosis and Correlates with Clinical Disability.
Kinetics of Proinflammatory Monocytes in a Model of Multiple Sclerosis and Its Perturbation by Laquinimod.
Internal jugular vein entrapment in a multiple sclerosis patient.
Switching therapy from natalizumab to fingolimod in relapsing-remitting multiple sclerosis: clinical and magnetic resonance imaging findings.
Psychiatric disorders revealing multiple sclerosis after 20 years of evolvement.
[The role of regulatory T cells in the development of autoimmune process in multiple sclerosis].
[Affective and psychotic disorders in multiple sclerosis].
Cerebral arterial bolus arrival time is prolonged in multiple sclerosis and associated with disability.

Pages